{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:17:59Z","timestamp":1791613079324,"version":"4.3.4"},"reference-count":50,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T00:00:00Z","timestamp":1652832000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Unitaid"},{"name":"World Health Organization"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Despite the widespread availability of curative treatment with direct-acting antivirals, a significant proportion of people with HCV remain undiagnosed and untreated. New point-of-care (PoC) HCV RNA assays that can be used in clinical settings may help expand access to testing and treatment. This study aimed to evaluate the diagnostic performance of PoC HCV viral load assays compared to laboratory-based testing. Methods: We searched three databases for studies published before May 2021 that evaluated PoC HCV RNA assays against a laboratory NAT reference standard (Prospero CRD42021269022). Random effects bivariate models were used to summarize the estimates. Stratified analyses were performed based on geographic region, population (PWID, etc.), and specimen type (serum\/plasma or fingerstick; fresh or frozen). We used the GRADE approach to assess the certainty of the evidence. Results: A total of 25 studies were eligible. We evaluated five different commercially available viral load assays. The pooled sensitivity and specificity were 99% (95% CI: 98\u201399%) and 99% (95% CI: 99\u2013100%), respectively. High sensitivity and specificity were observed across different assays, study settings (including LMICs and HICs), and populations. There was a small but statistically significant reduction in sensitivity for fingersticks compared to serum or plasma samples (98% vs. 100%, p &lt; 0.05), but the specificity was similar between frozen and fresh samples. The evidence was rated as moderate-high certainty. Conclusions: PoC HCV viral load assays demonstrate excellent diagnostic performance in various settings and populations. The WHO now recommends using PoC HCV viral load assays as an additional strategy to promote access to confirmatory viral load testing and treatment.<\/jats:p>","DOI":"10.3390\/diagnostics12051255","type":"journal-article","created":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T11:59:37Z","timestamp":1652875177000},"page":"1255","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Diagnostic Accuracy of Point-of-Care HCV Viral Load Assays for HCV Diagnosis: A Systematic Review and Meta-Analysis"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9026-707X","authenticated-orcid":false,"given":"Weiming","family":"Tang","sequence":"first","affiliation":[{"name":"University of North Carolina Project-China, Guangzhou 510095, China"},{"name":"Institute for Global Health and Infectious Diseases, University of North Carolina at Chaple Hill, Chapel Hill, NC 27599, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusha","family":"Tao","sequence":"additional","affiliation":[{"name":"University of North Carolina Project-China, Guangzhou 510095, China"},{"name":"Institute for Global Health and Infectious Diseases, University of North Carolina at Chaple Hill, Chapel Hill, NC 27599, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7561-3368","authenticated-orcid":false,"given":"Emmanuel","family":"Fajardo","sequence":"additional","affiliation":[{"name":"Department of Global HIV, Hepatitis and STI Programmes, World Health Organization, 1211 Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena Ivanova","family":"Reipold","sequence":"additional","affiliation":[{"name":"FIND, The Global Alliance for Diagnostics, 1202 Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Chou","sequence":"additional","affiliation":[{"name":"Departments of Medicine, Oregon Health & Science University, Portland, OR 97239, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph D.","family":"Tucker","sequence":"additional","affiliation":[{"name":"University of North Carolina Project-China, Guangzhou 510095, China"},{"name":"Institute for Global Health and Infectious Diseases, University of North Carolina at Chaple Hill, Chapel Hill, NC 27599, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippa","family":"Easterbrook","sequence":"additional","affiliation":[{"name":"Department of Global HIV, Hepatitis and STI Programmes, World Health Organization, 1211 Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,5,18]]},"reference":[{"key":"ref_1","unstructured":"WHO (2021). Global Progress Report on Hiv, Viral Hepatitis And Sexually Transmitted Infections, 2021, WHO."},{"key":"ref_2","unstructured":"WHO (2016). Global Health Sector Strategu on Viral Hepatitis 2016\u20132021, WHO."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e25050","DOI":"10.1002\/jia2.25050","article-title":"How far are we from viral hepatitis elimination service coverage targets?","volume":"21","author":"Hutin","year":"2018","journal-title":"J. Int. AIDS Soc."},{"key":"ref_4","unstructured":"WHO (2017). WHO Global Hepatitis Report 2017, World Health Organization."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e431","DOI":"10.1016\/S2214-109X(20)30505-2","article-title":"Decentralisation, integration, and task-shifting in hepatitis C virus infection testing and treatment: A global systematic review and meta-analysis","volume":"9","author":"Oru","year":"2021","journal-title":"Lancet Glob. Health"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/COH.0000000000000370","article-title":"Diagnosis of viral hepatitis","volume":"12","author":"Easterbrook","year":"2017","journal-title":"Curr. Opin. HIV AIDS"},{"key":"ref_7","first-page":"11","article-title":"Impact of hepatitis C virus (HCV) point-of-care viral load testing compared to laboratory-based testing on uptake of testing and treatment, and turnaround times: A systematic review and meta-analysis","volume":"57","author":"Trikey","year":"2021","journal-title":"Int. J. Drug Policy"},{"key":"ref_8","unstructured":"ISO (2006). Point-of-Care Testing (POCT)\u2014Requirements for Quality and Competence, ISO."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: Explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.3348\/kjr.2015.16.6.1188","article-title":"Systematic review and meta-analysis of studies evaluating diagnostic test accuracy: A practical review for clinical researchers-part II. Statistical methods of meta-analysis","volume":"16","author":"Lee","year":"2015","journal-title":"Korean J. Radiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jclinepi.2011.11.014","article-title":"Assessing risk of bias in prevalence studies: Modification of an existing tool and evidence of interrater agreement","volume":"65","author":"Hoy","year":"2012","journal-title":"J. Clin. Epidemiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"ref_14","unstructured":"Siemieniuk, R., and Guyatt, G. (2021, September 09). BMJ Best Practice: What Is GRADE?. Available online: https:\/\/bestpractice.bmj.com\/info\/toolkit\/learn-ebm\/what-is-grade\/."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1136\/bmj.39500.677199.AE","article-title":"Grading quality of evidence and strength of recommendations for diagnostic tests and strategies","volume":"336","author":"Oxman","year":"2008","journal-title":"BMJ"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jclinepi.2015.12.007","article-title":"Improving GRADE evidence tables part 1: A randomized trial shows improved understanding of content in summary of findings tables with a new format","volume":"74","author":"Santesso","year":"2016","journal-title":"J. Clin. Epidemiol."},{"key":"ref_17","unstructured":"FIND (2019). Multicentre Clinical Performance Evaluation of the Molbio Diagnostics Truenat\u2122 HCV RNA Assay, HIV-NAT."},{"key":"ref_18","unstructured":"Assennato, S., Ritvhie, A., Sembongi, H., Ivanova, E., Stepchenkova, T., and Lee, H. (2019). SAMBA I I HCV: A New Point of Care Molecular Assy for HCV Diagnostic and DDA Monitoring."},{"key":"ref_19","unstructured":"Mehta, V., Ivanova, E., Vetter, B., Sarin, S., Ramachandran, B., and Gupta, E. (2020, January 4\u20138). Clinical performance evaluation of the Molbio Diagnostics TruenatTM HCV RNA assay: A near point-of-care test to strengthen Hepatitis C virus diagnostics. Proceedings of the 29th Annual Conference of Asian Pacific Association for the Study of the Liver, Bali, Indonesia."},{"key":"ref_20","unstructured":"Mboup (2021). Evaluation Report of the Clinical Performance of Genedrive Point-of-Care Test for Qualitative Detection of Hepatitis C Virus."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1093\/infdis\/jiy114","article-title":"Evaluation of the Xpert HCV Viral Load Finger-Stick Point-of-Care Assay","volume":"217","author":"Lamoury","year":"2018","journal-title":"J. Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0950268820002812","article-title":"Evaluation of the Point of Care Molecular Diagnostic Genedrive HCV ID Kit for the detection of HCV RNA in clinical samples","volume":"18","author":"Padhi","year":"2020","journal-title":"Epidemiol. Infect."},{"key":"ref_23","unstructured":"WHO (2020). WHO Prequalification of In Vitro Diagnostics, WHO."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1136\/gutjnl-2017-315783","article-title":"Development and clinical validation of the Genedrive point-of-care test for qualitative detection of hepatitis C virus","volume":"67","author":"Llibre","year":"2018","journal-title":"Gut"},{"key":"ref_25","first-page":"182","article-title":"Evaluation of GeneXpert for Quantification Viral Load Hepatitis C Virus","volume":"21","author":"Jasirwan","year":"2020","journal-title":"Indones. J. Gastroenterol. Hepatol. Dig. Endosc."},{"key":"ref_26","first-page":"117","article-title":"Improving Linkage to Care of Hepatitis C: Clinical Validation of GeneXpert(R) HCV Viral Load Point-of-Care Assay in Indonesia","volume":"105","author":"Thedja","year":"2021","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/jvh.13284","article-title":"Validation of hepatitis C virus RNA detection using capillary blood by finger prick (GenXpert system)-Hepatitis C fingerprick study","volume":"27","author":"Bielen","year":"2020","journal-title":"J. Viral. Hepat."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/liv.14315","article-title":"In-field evaluation of Xpert(R) HCV viral load Fingerstick assay in people who inject drugs in Tanzania","volume":"40","author":"Mohamed","year":"2020","journal-title":"Liver Int."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1002\/hsr2.151","article-title":"Elbasvir and grazoprevir for hepatitis C virus genotype 1 infection in people with recent injecting drug use (DARLO-C): An open-label, single-arm, phase 4, multicentre trial","volume":"3","author":"Grebely","year":"2020","journal-title":"Health Sci. Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"102734","DOI":"10.1016\/j.drugpo.2020.102734","article-title":"Evaluation of the Xpert HCV VL Fingerstick point-of-care assay and dried blood spot HCV-RNA testing as simplified diagnostic strategies among people who inject drugs in Catalonia, Spain","volume":"80","author":"Saludes","year":"2020","journal-title":"Int. J. Drug Policy"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1111\/liv.14242","article-title":"Point-of-care HCV RNA testing in the setting of DAA therapy: HCV-FiS (HEpatitis C Virus Fingerstick Study)","volume":"39","author":"Calvaruso","year":"2019","journal-title":"Liver Int."},{"key":"ref_32","first-page":"w20137","article-title":"Rapid point-of-care HCV RNA quantification in capillary whole blood for diagnosing chronic HCV infection, monitoring treatment and detecting reinfection","volume":"149","author":"Bregenzer","year":"2019","journal-title":"Swiss. Med. Wkly."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jcv.2019.06.007","article-title":"The new Xpert HCV viral load real-time PCR assay accurately quantifies hepatitis C virus RNA in serum and whole-blood specimens","volume":"117","author":"Wlassow","year":"2019","journal-title":"J. Clin. Virol."},{"key":"ref_34","unstructured":"WHO (2017). WHO Prequalification of In Vitro Diagnostics, WHO."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/jvh.13002","article-title":"Field evaluation of GeneXpert((R)) (Cepheid) HCV performance for RNA quantification in a genotype 1 and 6 predominant patient population in Cambodia","volume":"26","author":"Iwamoto","year":"2019","journal-title":"J. Viral Hepat."},{"key":"ref_36","unstructured":"FIND (2017). Evaluation of the Diagnostic Performance of the Xpert\u00ae Fingerstick HCV Viral Load (VL) Assay, HIV-NAT."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jcv.2017.01.006","article-title":"Point -of -care testing (POCT) in molecular diagnostics: Performance evaluation of GeneXpert HCV RNA test in diagnosing and monitoring of HCV infection","volume":"88","author":"Gupta","year":"2017","journal-title":"J. Clin. Virol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1128\/JCM.02460-16","article-title":"Multicenter Evaluation of the Cepheid Xpert Hepatitis C Virus Viral Load Assay","volume":"55","author":"McHugh","year":"2017","journal-title":"J. Clin. Microbiol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Lamoury, F.M.J., Njouom, R., Amougou-Atsama, M., Yiagnigni Mfopou, E., Berishvili, N., Sologashvili, M., Fajardo, E., Malobela, A., Mace, A., and Chirehwa, M. (2021). Diagnostic Performance and Usability of the Genedrive((R)) HCV ID Kit in Two Decentralized Settings in Cameroon and Georgia. Diagnostics, 11.","DOI":"10.3390\/diagnostics11050746"},{"key":"ref_40","unstructured":"FIND (2018). Prospective Evaluation of the Genedrive\u00ae HCV ID Kit in Georgia, HIV-NAT."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drugpo.2017.07.002","article-title":"Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs: A systematic review","volume":"47","author":"Bajis","year":"2017","journal-title":"Int. J. Drug Policy"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/ofid\/ofaa196","article-title":"Assessing molecular point-of-care testing and dried blood spot for hepatitis C virus screening in people who inject drugs","volume":"7","author":"Chevaliez","year":"2020","journal-title":"Open Forum Infect. Dis."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Bristow, C.C., Kojima, N., Lee, S.-J., Leon, S.R., Ramos, L.B., Konda, K.A., Brown, B., Caceres, C.F., and Klausner, J.D. (2018). HIV and syphilis testing preferences among men who have sex with men and among transgender women in Lima, Peru. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0206204"},{"key":"ref_44","unstructured":"Trickey, A., Fajardo, E., Alemu, D., Artenie, A.A., and Easterbrook, P. (2021, January 18). Impact of hepatitis C virus (HCV) point-of-care viral load testing compared to laboratory-based testing on uptake of testing and treatment, and turnaround times: A systematic review and meta-analysis. Proceedings of the WHO HCV Guideline Development Meeting, Geneva, Switzerland."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.drugpo.2018.04.003","article-title":"Interventions to increase testing, linkage to care and treatment of hepatitis C virus (HCV) infection among people in prisons: A systematic review","volume":"57","author":"Kronfli","year":"2018","journal-title":"Int. J. Drug Policy"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.socscimed.2013.01.031","article-title":"Taming systems to create enabling environments for HCV treatment: Negotiating trust in the drug and alcohol setting","volume":"83","author":"Harris","year":"2013","journal-title":"Soc. Sci. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11904-010-0071-3","article-title":"HIV\/HCV co-infection: Pathogenesis, clinical complications, treatment, and new therapeutic technologies","volume":"8","author":"Operskalski","year":"2011","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/ije\/dyg107","article-title":"Influence of maternal human immunodeficiency virus (HIV) co-infection on vertical transmission of hepatitis C virus (HCV): A meta-analysis","volume":"32","author":"Pappalardo","year":"2003","journal-title":"Int. J. Epidemiol."},{"key":"ref_49","unstructured":"World Health Organization (2015). Consolidated Guidelines on HIV Testing Services, WHO."},{"key":"ref_50","unstructured":"World Health Organization (2013). Xpert MTB\/RIF Assay for the Diagnosis of Pulmonary and Extrapulmonary TB in Adults and Children, WHO."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/12\/5\/1255\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:14:05Z","timestamp":1760138045000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/12\/5\/1255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,18]]},"references-count":50,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5]]}},"alternative-id":["diagnostics12051255"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics12051255","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,18]]}}}